| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | NewGenIvf legt operatives Update für mehrere Geschäftsbereiche vor | 1 | Investing.com Deutsch | ||
| Mo | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 21.10. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 07.10. | NewGenIvf GAAP EPS of -$26.64 misses by $44.82, revenue of $1.92M misses by $18.18M | 2 | Seeking Alpha | ||
| 07.10. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.10. | NewGenIvf (NIVF) Stock Soars Over 28% After-Hours: What's Driving the Surge? | 3 | Benzinga.com | ||
| 30.09. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.09. | NewGenIvf schließt öffentliches Angebot über 1,25 Mio. US-Dollar ab | 1 | Investing.com Deutsch | ||
| 30.09. | NewGenIvf closes $1.25M public offering at $0.07/share | 1 | Investing.com | ||
| 30.09. | NewGenIVF Group Limited: NewGen Announces Closing of $1.25 Million Public Offering | 4 | GlobeNewswire (USA) | ||
| 29.09. | NewGenIvf announces pricing of $1.25M public offering of shares and pre-funded warrants | 2 | Seeking Alpha | ||
| 29.09. | NewGenIvf prices $1.25M public offering at $0.07 per share | 1 | Investing.com | ||
| 29.09. | NewGenIVF Group Limited: NewGen Announces Pricing of $1.25 Million Public Offering | 1 | GlobeNewswire (USA) | ||
| 10.09. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 20.08. | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | 3 | SEC Filings | ||
| 17.08. | NewGenIVF Group Limited: NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 17.08. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.07. | NewGenIVF Group Limited: NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million | 508 | GlobeNewswire (Europe) | BANGKOK, July 27, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has entered... ► Artikel lesen | |
| 27.07. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | NewGenIVF Group Limited: NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million | 1 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,424 | +1,03 % | Truist raises Teladoc stock price target to $9 on EBITDA outlook | ||
| SERNOVA BIOTHERAPEUTICS | 0,066 | -1,50 % | Sernova Biotherapeutics-Aktie 19,8 % im Minus: 11,2 Millionen für die Fusion mit Seraxis | ||
| CERENOME | 0,474 | -27,04 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| ATOSSA THERAPEUTICS | 1,680 | +1,20 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Rekord bei Umsatz und Gewinn - lächerliche Bewertung! | Sonoma Pharmaceuticals macht den nächsten gewaltigen Schritt auf dem Weg zum profitablen Wachstumsunternehmen. Nach dem erstmaligen Erreichen eines positiven EBITDA im Vorquartal meldet der Healthcare-Spezialist... ► Artikel lesen | |
| TANDEM DIABETES | 16,100 | +3,21 % | Warum die Aktie von Tandem Diabetes Care heute kräftig zulegt | ||
| CO-DIAGNOSTICS | 0,197 | -0,25 % | Co-Diagnostics receives test order from Peru amid dengue rise | ||
| QUIDELORTHO | 8,994 | +2,98 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,300 | -0,43 % | Veru presents data on enobosarm for obesity treatment | ||
| LIFEWARD | 3,200 | 0,00 % | Lifeward GAAP EPS of -$1.32 misses by $0.50, revenue of $5.43M misses by $1.81M | ||
| CLOVER HEALTH INVESTMENTS | 3,870 | +1,84 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SENSEONICS | 9,400 | +5,62 % | Beta Bionics, Inc.: Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration | ||
| TEMPEST THERAPEUTICS | 0,310 | +0,06 % | Tempest Therapeutics GAAP EPS of -$0.21 beats by $0.11 | ||
| NANO-X IMAGING | 0,263 | +0,80 % | NANO-X IMAGING LTD: Nanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026 | ||
| IMUNON | 0,440 | +0,46 % | Imunon targets 50% OVATION-3 enrollment in Q1 2028 while aiming for interim analysis in Q1 2030 |